Oxytocin (OT) is widely used to induce labor in the clinical setting. However, its physiological role in normal human parturition remains unclear. We demonstrated the enhanced expression of OT receptor (OTR) mRNA in chorio-decidual tissue, using the polymerase chain reaction after the reverse transcriptase reaction (RT-PCR) 
Introduction
Oxytocin (OT),' one of the strongest uterotonins (uterine contractants), is used for the induction of labor in the clinical setting. Although it is thought to be crucial in the initiation of parturition, the mechanism whereby it does so is poorly understood. Uterine sensitivity to OT varies greatly and appropriate timing of its use is important for successful induction. In some subjects, a pharmacological dose of OT does not induce labor, while in others only a drop of OT induces hypertonic uterine contractions. The concentration of OT in maternal plasma during spontaneous parturition does not change significantly before and during parturition (1, 2) .
We have previously cloned a cDNA for human OT receptor (OTR), and we showed that the expression of OTR mRNA in the human myometrium was markedly increased at parturition (3); this indicated that the sensitivity of the myometrium to OT regulated the action of this agent, and confirmed the results of early studies with binding assay (4, 5) at transcriptional level. However, this finding does not explain the interrelationship between OT and other uterine contractants at parturition. OT infusion has been shown to raise plasma prostaglandin (PG) F2,, level only when the induction of labor succeeded (6) , and OT stimulation in vitro induced the production of PGF2,, in decidual cells (7) . PGF2, is also a potent uterotonin.
These studies suggest that OT not only directly contracts the myometrium, but that it also regulates myometrial contraction through stimulating the production of other uterotonins at the feto-maternal interface. This interface, which consists of the amnion, chorion laeve, and decidua, is ideally situated to regulate the signals from the fetus and/or outside the uterus to the myometrium at parturition.
In this study, we investigated the expression of the OTR gene at the feto-maternal interface during parturition, using the polymerase chain reaction after the reverse transcriptase reaction (RT-PCR) and Northern blot hybridization. We also determined the cellular localization of OTR in these tissues at the transcriptional and translational levels, using in situ hybridization and immunohistochemistry with a newly developed monoclonal antibody. Through these experiments we attempted to demonstrate the role of OTR at the feto-maternal interface during parturition.
Methods
Tissue preparation. Chorio-decidual membranes were obtained from subjects who underwent either vaginal or cesarean delivery, the indications for cesarean delivery being previous cesarean section, fetal anomaly, and dystocia (Table I) . Informed consent was obtained from all subjects. The tissue specimens for RNA preparation were immediately frozen in liquid nitrogen after separation from the amniotic membrane, and stored at -80°C. Tissues to be subjected to in situ hybridization and anti-cytokeratin immunohistochemistry were fixed with freshly prepared 4% paraformaldehyde in 0.1 M sodium phosphate buffer (PB; pH 7.4) for 24 h at 4°C. The fixed specimens were embedded in paraffin wax after dehydration by the conventional method. Tissues to be subjected to immunohistochemistry with anti-OTR antibody were immediately embedded in OCT (Miles Inc., Elkhart, IN), frozen in liquid nitrogen, and stored at -80°C until use.
Placental tissues were obtained after a vaginal delivery. Tissue samples were taken from the mid-part ofthe placenta to avoid contamination by extravillus trophoblasts or decidual tissue. These specimens were also frozen in liquid nitrogen after vigorous washing with saline, and were stored at -80°C until RNA extraction. Northern blot analysis. Poly(A)+ RNA was isolated from total RNA by using oligo(dT)-latex beads (Oligotex-dT30; Takara, Kyoto, Japan); 1 Mg of the poly(A)+ RNA was then electrophoresed on a 1% agarose-2.2 M formaldehyde gel, and blotted onto nylon membrane filters (Geenscreen; NEN DuPont, Boston, MA). The filters were hybridized at 43°C for 16 h with a 0.8-kb BamHI-PstI fragment of the OTR cDNA, which was labeled with 32P by the random primer method. The filters were washed for 1 h at 50°C in 0.2x SSC buffer, containing 0.1% SDS, and were exposed to Kodak XAR film (Eastman Kodak Co., Rochester, NY) for 24 h with two intensifying screens at -70°C. The filters were also exposed to an imaging plate (Fuji Photo Film Co., Tokyo, Japan) for one hour, from which quantitative analysis was performed with imaging plate scanners (BAS2000; Fuji Photo Film Co.).
After analysis, the filters were dehybridized and rehybridized with a 32P-labeled fl-actin cDNA fragment (Wako Pure Chemical Industries, Osaka, Japan) as an internal control. In situ hybridization histochemistry. Digoxigenin-labeled single strand RNA probes were prepared, using a DIG RNA Labeling Kit (Boehringer Mannheim) according to the manufacturer's instructions. For the generation of human OTR-specific probes, three firaments of oxytocin receptor cDNA were subcloned into Bluescript I plasmid; a BglII-and DraI-digested 255-bp (3035-3289) fragment (OTR255), a PstI-and Apal-digested 388-bp (686-1074) fragment (OTR388), and a PstI-digested 484-bp (1079-1562) fragment (OTR484). The plasmids were linearized with the appropriate enzymes, and transcribed with T3 or T7 RNA polymerase to generate antisense or sense cRNA probes.
In situ hybridization was carried out as described previously (10 Immunohistochemistry. The frozen embedded tissues, which were obtained after normal delivery, were sectioned and fixed with acetone for 10 min on glass slides. These sections were then treated for 30 min with methanol containing 0.3% hydrogen peroxide to eliminate intrinsic peroxidase activity. Immunohistological staining was performed using the Vectastain ABC Kit (Vector Laboratories Inc., Burlingame, CA) according to the manufacturer's instructions with 0.45 mol/I sodiumchloride in the buffer for primary antibody. The anti-OTR monoclonal antibody 2F8 (10 Mg/ml), was used as the primary antibody. The incubation time for the primary and secondary antibody were 30 min each at room temperature. A mixture of equal amounts of 0.02% hydrogen peroxide and 0. 1% DAB solution was used as the color substrate solution. The specificity of the antibody was comfirmed by (a) using normal mouse IgM fraction as the primary antibody, and (b) addition of the 5 ug/ml synthetic peptide to neutralize the primary antibody.
The localization oftrophoblast in the same specimens used in the in situ hybridization was shown by immunohistological staining using anti-cytokeratin monoclonal antibody (10 Mg/ml) (Shandon Inc. Pittsburgh, PA) as the primary antibody.
Results
RT-PCR. To determine the expression of OTR mRNA in chorion-decidua, we examined, by RT-PCR, the tissues from three subjects before the onset of labor (Fig. 1, lanes 1-3) and three after normal parturition (Fig. 1, lanes 4-6) . 25 cycles of PCR amplification after the reverse transcriptase reaction yielded products derived from OTR mRNA only in the tissues of the three subjects examined after parturition (Fig. 1 A) . On 30 cycles of PCR, the amplified product of OTR mRNA was detected in the tissues of the three subjects before the onset of labor as well as in those after parturition, indicating that the expression level of OTR mRNA may increase during parturition. However, no detectable product was obtained in two samples of placental trophoblasts (Fig. 1 B, lanes 7, 8) . 15 (4, 5, 6) , and placental trophoblast after normal parturition (7, 8) were cycles with a #-actin primer pair demonstrated that comparable amounts of RNA were used for the reaction (Fig. 1 C) .
Estimation of OTR mRNA expression in chorion-decidua by Northern blot analysis. To quantify OTR mRNA expression in the chorion-decidua during parturition, poly(A)+ RNA was extracted from the chorion-decidua at various stages ofparturition (Table I) , and was hybridized with the OTR cDNA probe. The stage of parturition was evaluated by the conditions of uterine contraction and the dilatation of the uterine cervix. The quantification was carried out by comparing OTR mRNA expression with the expression of,B-actin mRNA as an internal control (Fig. 2) . The relative amount of OTR mRNA was determined by quantitative analysis, using an imaging plate analyzer. Small amounts of OTR mRNA were detected in the three chorion-decidua specimens taken prior to the onset of labor (Fig. 2, lanes 1-3) . OTR mRNA increased dramatically with the onset oflabor, showing good correlation with cervical dilatation, and reached a peak at the completion ofparturition (Fig. 2, lanes 4-9) . The intensity of the signal was approximately five times that before the onset of labor.
Localization ofOTR mRNA. In situ hybridization was performed to determine the localization of OTR mRNA in the (Table I) were electrophoresed and transferred to a nylon membrane filter, as described in Methods. The lane numbers correspond to the case numbers in Table I . The filters, hybridized with a 32P-labeled 0.8-kb BamHI-PstI fragment of OTR cDNA (A), and rehybridized with a f#-actin cDNA fragment (B), were exposed for 24 h. The expression ofOTR mRNA was quantified by imaging plate scanner, and standardized by the expression of fl-actin.
The relative amount ofOTR mRNA was indicated (C). One arbitarary unit is defined as the level of OTR mRNA in lane 2.
chorion and the decidua. The sections of fetal membrane and decidua were hybridized with digoxigenin labeled cRNA probes. In sections taken from subjects in labor, hybridized signals were detected in the chorion laeve (Fig. 3 A) , the vascular rich decidual layer (Fig. 3 C) , and in large cobblestone-like decidual cells adjacent to the myometrium (Fig. 3 E) . Faint signals were observed in sections taken before the onset oflabor (data not shown). Adjacent sections were stained with anti-cytokeratin antibody, a trophoblast marker. Cytokeratin-positive chorionic trophoblasts also showed positive hybridization for OTR mRNA (Fig. 3, G and H) , indicating that the fetally derived chorionic trophoblasts, as well as the maternally derived decidual cells, expressed OTR mRNA.
Localization of OTR protein.
To examine the localization of OTR at the translational level, frozen sections offetal membrane were stained with the newly developed anti-OTR monoclonal antibody, 2F8. Reactions were observed in cells both in the chorion laeve and the decidual layer (Fig. 4) . The distribution pattern of OTR protein was consistent with that of OTR mRNA obtained by in situ hybridization.
Discussion
In this study, we determined the spatial and temporal expression of OTR mRNA and protein during parturition. By RT-PCR and Northern hybridization, we showed that the expression level ofOTR mRNA in chorion-decidua was increased up to fivefold during the course ofparturition. Some previous studies, in which a binding assay using labeled OT was used (5, 12) , suggested that the decidual binding sites of OT were increased at the end of pregnancy; however, whether this was due to an increase in the number of OTR molecules or to the expression of some other OT binding protein was not elucidated. Our results, measuring transcripts level, are in agreement with these earlier binding assays. We have indicated that upregulation of OTR concentrations seen at parturition is primarily regulated at the transcriptional level.
The in situ hybridization, together with anti-cytokeratin antibody immunohistochemistry, demonstrated OTR mRNA not only in decidual cells but also in the trophoblasts of the chorion laeve, while the trophoblasts in the placenta expressed no OTR mRNA (Fig. 1 B, lanes 7and 8 ), suggesting differences between the trophoblasts in the chorion laeve, and these in the placenta. The expression of OTR mRNA and protein in the amnion, the other fetally derived tissue at the feto-maternal interface, seems much lower than that of trophoblasts in the chorion laeve. In the previous studies, some investigators demonstrated the plenty amount of OT binding site in the amnion (13, 14) . However, our results are reproducible, and A.-R. Fuchs also demonstrated only trace amount of OTR in the human amnion, using a binding assay (personal communication). We are now planning to quantitate the amount of OTR in the human amnion at transcriptional and translational level. In any case, the fetally derived chorionic trophoblasts and maternally derived decidual cells both participate in the regulation of human parturition through the OT function.
The in situ hybridization experiments also suggested the possibility that decidual cells lying next to the myometrium expressed higher OTR mRNA levels than did cells lying closer to the chorion. Thus, the highest expression ofOTR may occur Several cytokines have been shown to be involved in preterm labor induced by local infection (19) (20) (21) . Of interest in this regard, we recently analyzed the structure of the promoter region of the human OTR gene, and found several consensus sequences which have been reported to be affected by cytokines (unpublished data). Several studies also suggest an interrelationship between OT and PGF2. (22) (23) (24) (25) . PGF2, is a well known uterotonin widely used to induce labor as well as OT. It is reported that this PG is produced in decidua by the action of OT (4, 6) . This means PGF2. is situated at the downstream of OTR in the signal mechanisms of labor.
Taken together, our findings strongly support the hypothe- sis that OTR expression is a limiting factor of parturition, which was proposed in the previous reports (4, 5) . They also explain how OT may play a pivotal role in the onset of labor in the absence of significant changes in maternal plasma concentration. Further investigation of the regulatory mechanism of OTR gene expression is essential to elucidate the mechanisms responsible for human parturition. To this end, we are now investigating the biological significance of the upstream sequences in our laboratory.
